Groowe Groowe / Newsroom / AMGN
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

AMGN News

Amgen Inc

Global Medical Device Contract Manufacturing Market is Predicted to Cross the USD 190 Billion Mark by 2032, Owing to the Rising Demand for Advanced Healthcare Solutions | DelveInsight

globenewswire.com
TMO PFE AMGN BMY MRK DHR ABBV GOOG MSFT JNJ MDT BSX SYK EW ISRG EMR BIOX EXAS QRVO TER ADI TXN ON INTC NVDA AMD HPQ DELL IBM GE FISV ADP PAYX NOW CRM ORCL SAP ADSK CDNS SNPS AMAT INFY HPE LOGI ATHM BIIB GILD REGN VRTX AMRN AZN LLY NVS CRSP EDIT NTLA ALNY INCY XRAY COO MASI IRTC MRNA EMB ADMA ICUI HOLX LH DGX RDNT EVTC AFYA CHKP DDOG SMCI ALGN THRY PTC MCHP NXPI QCOM SWKS MU WDC STX

Levelpath Extends AI Procurement Platform with Invoice Automation to Protect Financial Accuracy and Capture Negotiated Savings From Receipt to Payment

businesswire.com
AMGN SIRI WU

Immunostimulant Market to Reach $288.82 billion, Globally, by 2034 at 9.9% CAGR: Allied Market Research

prnewswire.com
MRK PFE BNTX BMY AMGN MRNA

Global Market for Merkel Cell Carcinoma Driven by Key Players Like Merck & Bristol Myers Squibb

globenewswire.com
MRK BMY INCY AMGN

Cell and Gene Therapy Market Size to Worth USD 232.22 Billion, Rising at 24% CAGR by 2035

globenewswire.com
AMGN BIIB NVS PFE REGN NTLA ALNY

Delphia Therapeutics Appoints Leading Cancer Expert Steve Kelsey, M.D., to Board of Directors

businesswire.com
RMD MRNA PFE AMGN

Senior Pharma and Biotech Leaders to Convene for Industry Forum at San Francisco CEO Ahead of JP Morgan Healthcare Conference

accessnewswire.com
JPM JNJ AMGN MRK BMY REGN

Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

globenewswire.com
AMGN PFE LLY AZN BMY NVS SNY GSK UCB ARQT REGN INCY ABBV BIIB MRK JNJ VNDA RAPT CHAI ONON ION ASMB CRVS APG KSCP KYMR XBI IBB ADSK CDNS SNPS

Bronchiectasis Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035

globenewswire.com
AMGN AZN GILD TEVA

John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), to Deliver Keynote Address on the Future of Biotech and Rare Disease Innovation at the 2026 MDA Clinical & Scientific Conference

globenewswire.com
AMGN REGN GILD BMY AZN NVS ARGX BIIB BBIO SRRK